Aster Capital Management’s Avalo Therapeutics AVTX Stock Holding History
Bought
Maintained
Sold
Other funds holding AVTX
Aster Capital Management's AVTX Position: Q3 2026 in Review
Aster Capital Management opened a new position in Avalo Therapeutics (AVTX) in Q3 2026: 598 shares worth $9.17K. The stake represents ﹤0.01% of the portfolio and ranks #788 among its holdings.
148 funds tracked by Wall St. Rank hold AVTX as of Q3 2026.
- Aster Capital Management held 598 shares of Avalo Therapeutics worth $9.17K as of Q3 2026.
- Avalo Therapeutics was a new Aster Capital Management position in Q3 2026.
- Avalo Therapeutics made up ﹤0.01% of Aster Capital Management's portfolio in Q3 2026, its #788 holding.
- 148 funds tracked by Wall St. Rank held Avalo Therapeutics as of Q3 2026.
Based on Aster Capital Management's 13F filing for Q3 2026, filed 12 Nov 2026.